Annual EBIT
-$242.65M$54.85M-29.20%
Summary
- Current Value
- As of today, AGL annual EBIT is -$242.65M, down -29.20% on
- Historical Performance
- AGL annual EBIT is up +35.61% over the past 3 years, and down -129.74% over the past 5 years
- All-Time High Comparison
- AGL annual EBIT is currently -347.63% below its historical high of -$54.21M set on
- 3-Year Low Comparison
- AGL annual EBIT is at its 3-year low
- Sector Comparison
- AGL annual EBIT is higher than 6.62% of companies in Healthcare sector
EBIT Chart
Add series to chart1/6
Series
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBIT | -$242.65M | -29.2% | +35.6% | -129.7% | -129.7% | |
| Quarterly EBIT | -$127.18M | +3.7% | -338.5% | -1192.0% | -2080.0% | |
| TTM EBIT | -$369.34M | -7.5% | -314.0% | -2081.6% | -6230.8% | |
| Price | $0.99 | -73.1% | -95.2% | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $6.06B | +40.4% | +230.5% | +662.9% | +662.9% | |
| Annual EPS | -$0.61 | -16.3% | +39.9% | +15.4% | +15.4% | |
| Annual EBITDA | -$218.19M | -30.1% | +39.8% | -239.8% | -239.8% | |
| Annual Net Income | -$250.28M | -28.2% | +38.3% | -118.7% | -118.7% |
EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$86.19M | N/A | -181.5% |
| 5Y | -$54.21M | N/A | -347.6% |
| All | -$54.21M | -347.6% |
EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$242.65M | at low | |
| 5Y | -$376.83M | +35.6% | |
| All | -$376.83M | +35.6% |
EBIT History
| Year | Value | Change |
|---|---|---|
| -$242.65M | -29.2% | |
| -$187.80M | -117.9% | |
| -$86.19M | +77.1% |
| Year | Value | Change |
|---|---|---|
| -$376.83M | -595.2% | |
| -$54.21M | +48.7% | |
| -$105.62M | - |
FAQ
What is the current annual EBIT of AGL?
As of today, AGL annual EBIT is -$242.65M
What is 1-year change in AGL annual EBIT?
AGL annual EBIT is down -29.20% year-over-year
What is 3-year change in AGL annual EBIT?
AGL annual EBIT is up +35.61% over the past 3 years
How far is AGL annual EBIT from its all-time high?
AGL annual EBIT is currently -347.63% below its historical high of -$54.21M set on December 31, 2020
How does AGL annual EBIT rank versus sector peers?
AGL annual EBIT is higher than 6.62% of companies in Healthcare sector
When is AGL next annual earnings release?
The next annual earnings release for AGL is on
Quarterly EBIT
-$127.18M$11.27M-9.73%
Summary
- Current Value
- As of today, AGL quarterly EBIT is -$127.18M, down -9.73% on
- Historical Performance
- AGL quarterly EBIT is up +3.69% year-over-year, and down -338.47% over the past 3 years
- All-Time High Comparison
- AGL quarterly EBIT is currently -13361.94% below its historical high of $959.00K set on
- 3-Year Low Comparison
- AGL quarterly EBIT is +22.59% above its 3-year low of -$164.30M reached on
- Sector Comparison
- AGL quarterly EBIT is higher than 2.15% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBIT | -$127.18M | -9.7% | +3.7% | -338.5% | -1192.0% | |
| Annual EBIT | -$242.65M | – | -29.2% | +35.6% | -129.7% | |
| TTM EBIT | -$369.34M | +1.3% | -7.5% | -314.0% | -2081.6% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $1.44B | +2.9% | -1.1% | +106.6% | +359.0% | |
| Quarterly EPS | -$0.27 | -5.4% | +6.0% | -259.3% | -777.6% | |
| Quarterly EBITDA | -$119.75M | -10.3% | +4.8% | -368.6% | -1787.9% | |
| Quarterly Net Income | -$110.21M | -5.6% | +5.3% | -261.3% | -795.9% |
Quarterly EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$21.59M | -489.2% | |
| 3Y | $605.00K | >-9999.0% | |
| 5Y | $959.00K | >-9999.0% | |
| All | $959.00K | >-9999.0% |
Quarterly EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$127.18M | at low | |
| 3Y | -$164.30M | +22.6% | |
| 5Y | -$298.36M | +57.4% | |
| All | -$298.36M | +57.4% |
Quarterly EBIT History
FAQ
What is the current quarterly EBIT of AGL?
As of today, AGL quarterly EBIT is -$127.18M
What is AGL quarterly EBIT most recent change?
AGL quarterly EBIT was down -9.73% on September 30, 2025
What is 1-year change in AGL quarterly EBIT?
AGL quarterly EBIT is up +3.69% year-over-year
How far is AGL quarterly EBIT from its all-time high?
AGL quarterly EBIT is currently -13361.94% below its historical high of $959.00K set on March 31, 2022
How does AGL quarterly EBIT rank versus sector peers?
AGL quarterly EBIT is higher than 2.15% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
TTM EBIT
-$369.34M$4.87M+1.30%
Summary
- Current Value
- As of today, AGL TTM EBIT is -$369.34M, up +1.30% on
- Historical Performance
- AGL TTM EBIT is down -7.49% year-over-year, and down -314.01% over the past 3 years
- All-Time High Comparison
- AGL TTM EBIT is currently -6230.79% below its historical high of -$5.83M set on
- 3-Year Low Comparison
- AGL TTM EBIT is +1.30% above its 3-year low of -$374.21M reached on
- Sector Comparison
- AGL TTM EBIT is higher than 3.13% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBIT | -$369.34M | +1.3% | -7.5% | -314.0% | -2081.6% | |
| Annual EBIT | -$242.65M | – | -29.2% | +35.6% | -129.7% | |
| Quarterly EBIT | -$127.18M | -9.7% | +3.7% | -338.5% | -1192.0% | |
| Price | $0.99 | +0.5% | -73.1% | -95.2% | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $5.89B | -0.3% | +5.2% | +137.2% | +555.9% | |
| TTM EPS | -$0.78 | +2.1% | +5.2% | -195.7% | -750.0% | |
| TTM EBITDA | -$341.22M | +1.8% | -6.3% | -350.7% | -5082.6% | |
| TTM Net Income | -$322.90M | +1.9% | -3.8% | -198.3% | -1267.8% |
TTM EBIT Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$283.96M | N/A | -30.1% |
| 3Y | -$106.12M | N/A | -248.0% |
| 5Y | -$56.67M | N/A | -551.7% |
| All | -$5.83M | -6230.8% |
TTM EBIT Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$374.21M | +1.3% | |
| 3Y | -$374.21M | +1.3% | |
| 5Y | -$386.19M | +4.4% | |
| All | -$386.19M | +4.4% |
TTM EBIT History
FAQ
What is the current TTM EBIT of AGL?
As of today, AGL TTM EBIT is -$369.34M
What is AGL TTM EBIT most recent change?
AGL TTM EBIT was up +1.30% on September 30, 2025
What is 1-year change in AGL TTM EBIT?
AGL TTM EBIT is down -7.49% year-over-year
How far is AGL TTM EBIT from its all-time high?
AGL TTM EBIT is currently -6230.79% below its historical high of -$5.83M set on March 31, 2020
How does AGL TTM EBIT rank versus sector peers?
AGL TTM EBIT is higher than 3.13% of companies in Healthcare sector
When is AGL next earnings release?
The next earnings release for AGL is on
EBIT Formula
EBIT = − −
Data Sources & References
- AGL Official Website www.agilonhealth.com
- Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1831097/000162828025048839/0001628280-25-048839-index.htm
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1831097/000162828025007721/0001628280-25-007721-index.htm
- AGL Profile on Yahoo Finance finance.yahoo.com/quote/AGL
- AGL Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/agl